Recombinant human megakaryocyte growth and development factor (rHuMGDF), a ligand for c-Mpl, produces functional human platelets in vitro

E. S. Choi, M. Hokom, T. Bartley, Y. S. Li, H. Ohashi, T. Kato, J. L. Nichol, J. Skrine, A. Knudten, J. Chen, A. Hornkohl, G. Grampp, L. Sleeman, S. Cole, G. Trail, Takashi Kato

Research output: Contribution to journalArticle

87 Citations (Scopus)

Abstract

Platelet formation, occurring from bone marrow or lung megakaryocytes, has been difficult to study mechanistically. Recombinant human megakaryocyte growth and development factor (rHuMGDF), a recently described cytokine, has now been used to establish an in vitro system in which this important and little understood process occurs. CD34 + cells cultured with rHuMGDF develop into megakaryocytes which form long cytoplasmic extensions (proplatelets) that fragment into platelet-sized particles (in vitro platelets). Morphologically, in vitro and human plasma-derived platelets (control platelets) are virtually identical with respect to size, dense granule distribution and ultrastructural features. Functionally, in vitro and control platelets have similar aggregation and activation responses, and similarly incorporate mepacrine into dense granules. These findings suggest that rHuMGDF is sufficient to generate platelet-synthesizing megakaryocytes from CD34 + cells and provide an experimental setting in which the study of human platelet formation can be adequately performed.

Original languageEnglish
Pages (from-to)317-322
Number of pages6
JournalStem Cells
Volume13
Issue number3
Publication statusPublished - 1995
Externally publishedYes

Fingerprint

Thrombopoietin
Blood Platelets
Megakaryocytes
Quinacrine
In Vitro Techniques
Cultured Cells
Bone Marrow
Cytokines
Lung

Keywords

  • CD34 cells
  • Human
  • Megakaryocytes
  • MGDF
  • mpl ligand
  • Platelets
  • Proplatelets
  • Thrombopoietin

ASJC Scopus subject areas

  • Cell Biology

Cite this

Recombinant human megakaryocyte growth and development factor (rHuMGDF), a ligand for c-Mpl, produces functional human platelets in vitro. / Choi, E. S.; Hokom, M.; Bartley, T.; Li, Y. S.; Ohashi, H.; Kato, T.; Nichol, J. L.; Skrine, J.; Knudten, A.; Chen, J.; Hornkohl, A.; Grampp, G.; Sleeman, L.; Cole, S.; Trail, G.; Kato, Takashi.

In: Stem Cells, Vol. 13, No. 3, 1995, p. 317-322.

Research output: Contribution to journalArticle

Choi, ES, Hokom, M, Bartley, T, Li, YS, Ohashi, H, Kato, T, Nichol, JL, Skrine, J, Knudten, A, Chen, J, Hornkohl, A, Grampp, G, Sleeman, L, Cole, S, Trail, G & Kato, T 1995, 'Recombinant human megakaryocyte growth and development factor (rHuMGDF), a ligand for c-Mpl, produces functional human platelets in vitro', Stem Cells, vol. 13, no. 3, pp. 317-322.
Choi, E. S. ; Hokom, M. ; Bartley, T. ; Li, Y. S. ; Ohashi, H. ; Kato, T. ; Nichol, J. L. ; Skrine, J. ; Knudten, A. ; Chen, J. ; Hornkohl, A. ; Grampp, G. ; Sleeman, L. ; Cole, S. ; Trail, G. ; Kato, Takashi. / Recombinant human megakaryocyte growth and development factor (rHuMGDF), a ligand for c-Mpl, produces functional human platelets in vitro. In: Stem Cells. 1995 ; Vol. 13, No. 3. pp. 317-322.
@article{74af2fdd78884527949b7ed55b1e69f4,
title = "Recombinant human megakaryocyte growth and development factor (rHuMGDF), a ligand for c-Mpl, produces functional human platelets in vitro",
abstract = "Platelet formation, occurring from bone marrow or lung megakaryocytes, has been difficult to study mechanistically. Recombinant human megakaryocyte growth and development factor (rHuMGDF), a recently described cytokine, has now been used to establish an in vitro system in which this important and little understood process occurs. CD34 + cells cultured with rHuMGDF develop into megakaryocytes which form long cytoplasmic extensions (proplatelets) that fragment into platelet-sized particles (in vitro platelets). Morphologically, in vitro and human plasma-derived platelets (control platelets) are virtually identical with respect to size, dense granule distribution and ultrastructural features. Functionally, in vitro and control platelets have similar aggregation and activation responses, and similarly incorporate mepacrine into dense granules. These findings suggest that rHuMGDF is sufficient to generate platelet-synthesizing megakaryocytes from CD34 + cells and provide an experimental setting in which the study of human platelet formation can be adequately performed.",
keywords = "CD34 cells, Human, Megakaryocytes, MGDF, mpl ligand, Platelets, Proplatelets, Thrombopoietin",
author = "Choi, {E. S.} and M. Hokom and T. Bartley and Li, {Y. S.} and H. Ohashi and T. Kato and Nichol, {J. L.} and J. Skrine and A. Knudten and J. Chen and A. Hornkohl and G. Grampp and L. Sleeman and S. Cole and G. Trail and Takashi Kato",
year = "1995",
language = "English",
volume = "13",
pages = "317--322",
journal = "Stem Cells",
issn = "1066-5099",
publisher = "AlphaMed Press",
number = "3",

}

TY - JOUR

T1 - Recombinant human megakaryocyte growth and development factor (rHuMGDF), a ligand for c-Mpl, produces functional human platelets in vitro

AU - Choi, E. S.

AU - Hokom, M.

AU - Bartley, T.

AU - Li, Y. S.

AU - Ohashi, H.

AU - Kato, T.

AU - Nichol, J. L.

AU - Skrine, J.

AU - Knudten, A.

AU - Chen, J.

AU - Hornkohl, A.

AU - Grampp, G.

AU - Sleeman, L.

AU - Cole, S.

AU - Trail, G.

AU - Kato, Takashi

PY - 1995

Y1 - 1995

N2 - Platelet formation, occurring from bone marrow or lung megakaryocytes, has been difficult to study mechanistically. Recombinant human megakaryocyte growth and development factor (rHuMGDF), a recently described cytokine, has now been used to establish an in vitro system in which this important and little understood process occurs. CD34 + cells cultured with rHuMGDF develop into megakaryocytes which form long cytoplasmic extensions (proplatelets) that fragment into platelet-sized particles (in vitro platelets). Morphologically, in vitro and human plasma-derived platelets (control platelets) are virtually identical with respect to size, dense granule distribution and ultrastructural features. Functionally, in vitro and control platelets have similar aggregation and activation responses, and similarly incorporate mepacrine into dense granules. These findings suggest that rHuMGDF is sufficient to generate platelet-synthesizing megakaryocytes from CD34 + cells and provide an experimental setting in which the study of human platelet formation can be adequately performed.

AB - Platelet formation, occurring from bone marrow or lung megakaryocytes, has been difficult to study mechanistically. Recombinant human megakaryocyte growth and development factor (rHuMGDF), a recently described cytokine, has now been used to establish an in vitro system in which this important and little understood process occurs. CD34 + cells cultured with rHuMGDF develop into megakaryocytes which form long cytoplasmic extensions (proplatelets) that fragment into platelet-sized particles (in vitro platelets). Morphologically, in vitro and human plasma-derived platelets (control platelets) are virtually identical with respect to size, dense granule distribution and ultrastructural features. Functionally, in vitro and control platelets have similar aggregation and activation responses, and similarly incorporate mepacrine into dense granules. These findings suggest that rHuMGDF is sufficient to generate platelet-synthesizing megakaryocytes from CD34 + cells and provide an experimental setting in which the study of human platelet formation can be adequately performed.

KW - CD34 cells

KW - Human

KW - Megakaryocytes

KW - MGDF

KW - mpl ligand

KW - Platelets

KW - Proplatelets

KW - Thrombopoietin

UR - http://www.scopus.com/inward/record.url?scp=0029022246&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029022246&partnerID=8YFLogxK

M3 - Article

VL - 13

SP - 317

EP - 322

JO - Stem Cells

JF - Stem Cells

SN - 1066-5099

IS - 3

ER -